IGF2 and breast cancer: Not only DDR1 co-localizes with IR in response to the IR ligands Ins and IGF-2, but it also contributes to regulate IR expression, as well as ligand-dependent activation of signal transduction, energetic metabolism and biological responses in BC cells [55, 56].